General Information
Drug ID
DR00724
Drug Name
Dofetilide
Synonyms
1-(4-methanesulfonamidophenoxy)-2-(N-(4-methanesulfonamidophenethyl)-N-methylamine)ethane; 1-MSPMPE; Beta-((p-Methanesulfonamidophenethyl)methylamino)methanesulfono-p-phenetidide; Dofetilida; Dofetilida [INN-Spanish]; Dofetilide (JAN/USAN/INN); Dofetilide [USAN:BAN:INN]; Dofetilidum; Dofetilidum [INN-Latin];Tikosyn (TN); Methanesulfonamide, N-(4-(2-(methyl(2-(4-((methylsulfonyl)amino)phenoxy)ethyl)amino)ethyl)phenyl); N-(4-{2-[methyl(2-{4-[(methylsulfonyl)amino]phenoxy}ethyl)amino]ethyl}phenyl)methanesulfonamide; N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methylamino]ethyl]phenyl]methanesulfonamide; Tikosyn; Tikosyn, UK68798, Dofetilide; UK 68,798; UK 68798; UK-68,798; UK-68798; Xelide
Drug Type
Small molecular drug
Indication Maintenance of normal sinus rhythm [ICD11: BC81.3] Approved [1]
Therapeutic Class
Antiarrhythmic Agents
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=71329"></iframe>
3D MOL 2D MOL
Formula
C19H27N3O5S2
Canonical SMILES
CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
InChI
InChI=1S/C19H27N3O5S2/c1-22(13-12-16-4-6-17(7-5-16)20-28(2,23)24)14-15-27-19-10-8-18(9-11-19)21-29(3,25)26/h4-11,20-21H,12-15H2,1-3H3
InChIKey
IXTMWRCNAAVVAI-UHFFFAOYSA-N
CAS Number
CAS 115256-11-6
Pharmaceutical Properties Molecular Weight 441.561 Topological Polar Surface Area 122
Heavy Atom Count 29 Rotatable Bond Count 11
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 8
PubChem CID
71329
ChEBI ID
CHEBI:4681
TTD Drug ID
D0NW3X
DT(s) Transporting This Drug MATE1 Transporter Info Multidrug and toxin extrusion protein 1 Substrate [2]
MATE2 Transporter Info Multidrug and toxin extrusion protein 2 Substrate [2]
OCT2 Transporter Info Organic cation transporter 2 Substrate [2]
References
1 Dofetilide was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 FDA Drug Development and Drug Interactions

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.